Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Steven Craig (NPI 1134249832)

Field	Value
Entity Type	Individual
Organization	Steven Craig
Address	8421 Plum Dr
City	Urbandale
State	IA
ZIP	50322
Taxonomy	Rheumatology Physician
NPI Enumerated	March 29, 2007

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider’s revenue is effectively single‑payer: Total Medicare revenue is $1.7M and there is no Medicaid billing on file. The absence of any Medicaid claims indicates the practice’s commercial and network exposure is concentrated in the Medicare population rather than split across both public programs.

Revenue is highly concentrated in injectable biologic therapies: the precomputed top‑3 Medicare codes account for 56.7% of the provider’s Medicare revenue, driven by J0129 (23.0%), J0897 (18.6%), and J3262 (15.0%). This concentration means the practice’s financial performance is closely tied to administration and reimbursement for high‑cost specialty injectables.

The CPT/HCPCS mix signals a rheumatology practice that operates substantial in‑office infusion and injection services. Top drug codes include J0129 (abatacept), J0897 (denosumab), J3262 (tocilizumab) and additional biologics such as J0717, J1602 and J1745, while supportive codes for infusion/administration (96413, 96401, 96365) and bone health imaging/medication (77080, J3111) indicate integrated management of chronic autoimmune and bone‑metabolic conditions.

Competitive standing varies by product: the provider ranks notably above typical national volume on J0897 (rank #365 of 10057, 96th percentile; labeled "notably above typical national volume"), identifying him as a high‑volume national participant for denosumab. By contrast, J0129 (rank #387 of 1221, 68th percentile) and J3262 (rank #217 of 618, 65th percentile) are in the typical range, indicating routine participation rather than dominance for those agents.

Office visit volumes demonstrate an active outpatient panel: 99213 appears with 699 claims and $40.5K revenue, ranking #14308 of 457151 (97th percentile; noted as "notably above typical national volume"), and 99214 shows 523 claims and $43.4K revenue, ranking at the 90th percentile. These high percentiles for E/M codes support that the provider maintains steady clinic throughput in addition to infusion work.

Several administration and chemotherapy‑related codes are present among top billers, including 96413 (441 claims, $42.3K revenue) and 96401 (496 claims, $26.8K revenue). The presence of these administration/infusion CPTs alongside biologic J‑codes suggests the practice bills for both drug supply and the clinical services to give IV/subcutaneous therapies, which has operational implications for staffing, infusion space, and drug‑acquisition/coverage arrangements.

Certain procedure codes are unusually concentrated compared with peers: 20600 (rank #269 of 6502, 96th percentile; labeled "notably above typical national volume") and 82565 (rank #170 of 5066, 97th percentile) indicate above‑typical use of small‑joint procedures and creatinine testing respectively, pointing to procedure throughput and routine laboratory monitoring as part of ongoing rheumatologic care. Most other high‑revenue codes are characterized as "typical, unremarkable volume," underscoring that only a handful of services are outliers.

Provider tenure is long and stable: the NPI was enumerated on 2007-03-29 (~19 years ago), indicating nearly two decades of billing history under this enumeration. That longevity, combined with the Medicare revenue concentration and infusion‑centric code mix, suggests an established local practice built around biologic administration and outpatient rheumatology care.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

54 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	11,700	$30	$397.8K
J0897	Injection, denosumab, 1 mg	17,880	$20	$321.8K
J3262	Injection, tocilizumab, 1 mg	51,960	$10	$259.8K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	49,600	$1	$198.4K
J1602	Injection, golimumab, 1 mg, for intravenous use	15,600	$10	$171.6K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	3,030	$30	$90.8K
J3111	Injection, romosozumab-aqqg, 1 mg	6,720	$10	$53.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	520	$80	$43.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	440	$100	$42.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	700	$60	$40.5K

Showing 1–10 of 54

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 54 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Steven Craig — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

54 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3262	3	10	35,440	$1	$233.1K
J0129	4	20	5,950	$30	$218.3K
J1602	5	10	13,010	$10	$153.6K
J3111	17	20	12,180	$10	$112K
J0717	2	20	23,500	$1	$93.9K
J1745	21	20	3,460	$30	$92.3K
J0897	5	190	1,920	$20	$74.1K
Q5104	1	10	1,360	$30	$49.2K
96413	15	80	210	$90	$24K
99214	454	4,690	100	$70	$14.4K

Showing 1–10 of 54

Related Providers

Other providers that share a Tax Identification Number (TIN) with Steven Craig, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Thomas Buroker	IA	Medical Oncology Physician	$9.4M	$0
Kyle Alliman	IA	Ophthalmology Physician	$8.7M	$0
Alex Kartvelishvili	IA	Ophthalmology Physician	$8.1M	$0
Paul Boeke	IA	Ophthalmology Physician	$7.1M	$0
Austin Strohbehn	IA	Retina Specialist (Ophthalmology) Physician	$5.8M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Robert Behrens	IA	Medical Oncology Physician	$5.2M	$0
Matthew Mcknight	IA	Foot & Ankle Surgery Podiatrist	$4.7M	$23.5K
James Singer	IA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Christopher Haupert	IA	Retina Specialist (Ophthalmology) Physician	$3.9M	$0

Nearby Providers

Other providers in the same ZIP code as Steven Craig, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mosaic	IA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$177.4M
The Respite Connection, Inc.	IA	Community/Behavioral Health Agency	$0	$38.1M
Unitypoint At Home	IA	Durable Medical Equipment & Medical Supplies	$0	$16.5M
Unitypoint At Home	IA	Home Infusion Therapy Pharmacy	$0	$15.4M
New Beginnings Counseling Service, LLC	IA	Community/Behavioral Health Agency	$0	$6.3M
A-1 Iowa Dental PLLC	IA	Dentist	$0	$5.4M
Urbandale Community School District	IA	Local Education Agency (LEA)	$0	$4.4M
Primary Health Care, Inc.	IA	Federally Qualified Health Center (FQHC)	$0	$3.9M
Acs Medical LLC	IA	Durable Medical Equipment & Medical Supplies	$0	$3.6M
Wellserve Health, Inc.	IA	Community/Behavioral Health Agency	$0	$2.8M

Steven Craig — Billing Profile & Reimbursement Data

Sign up for Steven Craig — Billing Profile & Reimbursement Data policy alerts

Steven Craig — Billing Profile & Reimbursement Data

Sign up for Steven Craig — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References